Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Evaluation of the Exoskeleton ATLAS 2030 as Robot-assisted Physical Therapy to Children With Neuromuscular Diseases

NCT04837157 · MarsiBionics · Updated 8 April 2021

What is being tested
Exoskeleton rehabilitation
For
Cerebral Palsy; SMA II; Neuromuscular Diseases
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 3 years to 14 years. About 6 people. The full rules are on the registry page.
Where
Spain
When
Starts or started 15 Oct 2020, ends 31 Jan 2021. Registered 8 April 2021.
Results
None posted yet.

In the researchers' words

This study aims to evaluate the safety, usability and acceptability of a motorized mobility assistance exoskeleton. The protocol explores the use of the motorized device during static and dynamic rehabilitation sessions focused on walking and functional activities, with the expectation of evaluating the safety and usability of the device in the population studied. The protocol has been focused on defining how the device can be used appropriately in this population in a safe and effective manner by rehabilitation specialists. The study also aims to assess the safety of clinical staff who implement the intervention.
ClinicalTrials.gov, NCT04837157

Sites

  • MarsiCareArganda, Madrid, Spain